Is Semaglutide Tablet (Rybelsus) in shortage?
Semaglutide Tablet is listed by FDA as being discontinued by at least one maker (updated Jun 4, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Rybelsus, Tablet, 3 mg (NDC 0169-4303-30)
Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets.
Maker contact: 833-493-4689
- Rybelsus, Tablet, 7 mg (NDC 0169-4307-30)
Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets.
Maker contact: 833-493-4689
- Rybelsus, Tablet, 14 mg (NDC 0169-4314-30)
Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets.
Maker contact: 833-493-4689
FDA recalls of Semaglutide
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Semaglutide Tablet:
Semaglutide Tablet shortage questions
Is Semaglutide Tablet (Rybelsus) in shortage?
Semaglutide Tablet is listed by FDA as being discontinued by at least one maker (updated Jun 4, 2026).
What should I do if I can’t get Semaglutide Tablet?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.